ANTIBIOTIC.ru 

Р. Я. МЕШКОВА

РУКОВОДСТВО ПО ИММУНОПРОФИЛАКТИКЕ ДЛЯ ВРАЧЕЙ


Содержание | Виртуальная библиотека | Главная страница
Введение Вакцинация пациентов с отягощенным анамнезом. Рекомендуемые вакцины Прививочные реакции и осложнения
Иммунологические механизмы
противоинфекционной защиты
Тактика лечения детей с различной патологией до и после вакцинации Противопоказания к вакцинации
Вакцины, состав, техника вакцинации, вакцинные препараты. Разработка новых видов вакцин Некоторые аспекты иммунизации
взрослых
Приложение 1
Приложение 2
Стратегия вакцинации в России и других странах мира. Графики иммунизации Неотложные лечебные мероприятия при развитии поствакцинальных осложнений Словарь терминов
Список литературы

СПИСОК ЛИТЕРАТУРЫ

  1. Брагинская В.П., Соколова А.Ф. Активная иммунизация детей / М., Медицина, 1984.- 190 с.
  2. Вакцинопрофилактика (справочник для врачей под ред. В.К.Таточенко, Н.А.Озерецковского) / М., 1994.- 179 с.
  3. Вакцинопрофилактика гриппа (информационный сборник) / Москва-Санкт-Петербург, 1997.- 48 с.
  4. Караулов А.В. Инфекции и иммунодефициты – приоритеты сегодня // Практикующий врач.- 1997.- № 9.- С.3-4.
  5. Караулов А.В. Инфекции и иммунодефициты – приоритеты сегодня // Практикующий врач.- 1997.- N 3.- С.3-4.
  6. Костинов М.П. Новое в клинике, диагностике и вакцинопрофилактике управляемых инфекций / М., 1997.- 110 с.
  7. Костинов М.П. Вакцинация детей с нарушенным состоянием здоровья. Практическое руководство для врачей / М.,1996.- 78 с.
  8. Костинов М.П. Иммунокоррекция в педиатрии / М., 1997. 111 с.
  9. Краснуха. Синдром врожденной краснухи (информационный сборник) / М., 1998.- 64 с.
  10. Лесков В.П., Чередеев А.Н., Горлина Н.К. и др. Клиническая иммунология для врачей / М., 1997.- 124 с.
  11. Ляшенко В.А., Воробьев А.А. Молекулярные основы иммуногенности антигенов / М., Медицина, 1982.- 271 с.
  12. Мешкова Р.Я., Ковальчук Л.В., Коновалова М.И. Клиника, диагностика, лечение некоторых форм иммунодефицитов и аллергических заболеваний с основами организации службы клинической иммунологии / Смоленск, Полиграмма, 1995.- 173 с.
  13. Петров Р.В., Хаитов Р.М. Искусственные антигены и вакцины / М., Медицина, 1988.- 287 с.
  14. Рафальский В.В. Клиническое применение препаратов интерферона. / Смоленск, 1997.- 250 с.
  15. Таточенко В.К. Педиатру на каждый день (справочник по лекарственной терапии) / М., 1997.- 218 с.
  16. Таточенко В.К., Озерецковский Н.А., Федоров А.М. Вакцинопрофилактика / М., 1995.- 189 с.
  17. Хаитов Р.М., Пинегин Б.В. Иммунодиагностика и иммунотерапи нарушений иммунной системы // Практикующий врач.- 1997.- № 9.- С.5-13.
  18. Хаитов Р.М., Пинегин Б.В. Иммунодиагностика и иммунотерапия нарушений иммунной системы // Практикующий врач.- 1997.- № 9.- С.5-13.
  19. Юшков В.В., Юшкова Т.А. Иммунокорректоры / Пермь, 1997.- 63 с.
  20. Aickin R., Hill D., Kemp A. Measles immunisation in children with allergy to egg // BMJ.- 1994.- Vol.309.- P.223-225.
  21. Albert J.M., Ott H.J. Calcifying dermatomyositis following antitetanus vaccination // Arch Intern Med.- 1983.- Vol.143.- P.1457-1458.
  22. Albonico H.U. Arguments against routine mumps vaccination // Soz Praventivmed.- 1995.- Vol.40.- P.116-123.
  23. Allerdist H. Neurological complications following measles vaccination // Dev Biol Stand.- 1979.- Vol.43.- P.259-264.
  24. Alm J.S., Lilja G., Pershagen G., Scheynius A. Early BCG vaccination and development of atopy // Lancet.- 1997.- Vol.350.- P.400-403.
  25. Almenara Barrios J., Ruiz Jimenez M.A., Serrano Moya P., Martinez Pulido F. Evaluation of the Andalusia Vaccination Program in the Sierra de Cadiz Sanitary District // An Esp Pediatr.- 1992.- Vol.36.- P.437-440.
  26. Anderson R.M., Crombie J.A., Grenfell B.T. The epidemiology of mumps in the UK: a preliminary study of virus transmission, herd immunity and the potential of immunization // Epidemiol Infect.- 1987.- Vol.99.- P.65-84.
  27. Arya L.S., Ghai O.P., Saraya A.K. Thrombocytopenic purpura following DPT vaccination // Pediatr Hematol Oncol.- 1993.- Vol.10.- P.381-383.
  28. Asano Y., Itakura N., Hiroishi Y., Hirose S., Ozaki T., Kuno K., Nagai T., Yazaki T., Yamanishi K., Takahashi M. Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients // J.Infect Dis.- 1985.- Vol.152.- P.863-868.
  29. Autret E., Jonville-Bera A.P., Galy-Eyraud C., Hessel L. Thrombocytopenic purpura after single or combined vaccination against measles, mumps and rubella // Arch Pediatr.- 1996.- Vol.3.- P.393-394.
  30. Autret E., Jonville-Bera A.P., Galy-Eyraud C., Hessel L. Thrombocytopenic purpura after isolated or combined vaccination against measles, mumps and rubella // Therapie.- 1996.- Vol.51.- P.677-680.
  31. Barra A., Bremard-Oury C., Bajart A., Griscelli C., Fritzell B., Preud'homme J.L. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide and its tetanus toxoid conjugate in patients with recurrent infections of humoral immunodeficiency // Int J Clin Lab Res.- 1992.- Vol.21.- P.231-234.
  32. Battistini A., Ollari R., Dodi L. Anti-influenza vaccination in children // Pediatr Med Chir.- 1985.- Vol.7.- P.369-374.
  33. Baxter D.N. Measles immunization in children with a history of egg allergy // Vaccine.- 1996.- Vol.14.- P.131-134.
  34. Bayer A.S. Arthritis related to rubella: a complication of natural rubella and rubella immunization // Postgrad Med.- Vol.67.- P.131-134.
  35. Beck S.A., Williams L.W., Shirrell M.A., Burks A.W. Egg hypersensitivity and measles-mumps-rubella vaccine administration // Pediatrics.- 1991.- Vol.88.- P.913-917.
  36. Becker N.G., Rouderfer V. Simultaneous control of measles and rubella by multidose vaccination schedules // Math Biosci.- 1996.- Vol.131.- P.81-102.
  37. Beeler J., Varricchio F., Wise R. Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994) // Pediatr Infect Dis J.- 1996.- Vol.15.- P.88-90.
  38. Berger S.A., Ginsberg G.M., Slater P.E. Cost-benefit analysis of routine mumps and rubella vaccination for Israeli infants // Isr J Med Sci.- 1990.- Vol.26.- P.74-80.
  39. Bierman C.W., Shapiro G.G., Pierson W.E., Taylor J.W., Foy H.M., Fox J.P. Safety of influenza vaccination in allergic children // J Infect Dis.- 1977.- Vol.136.- Suppl: S6.- P.52-S655.
  40. Blom L., Nystrom L., Dahlquist G. The Swedish childhood diabetes study. Vaccinations and infections as risk determinants for diabetes in childhood // Diabetologia.- 1991.- Vol.34.- P.176-181.
  41. Bolan G., Broome C.V., Facklam R.R., Plikaytis B.D., Fraser D.W., Schlech W.F. 3d Pneumococcal vaccine efficacy in selected populations in the United States // Ann Intern Med.- 1986.- Vol.104.- P.1-6.
  42. Booy R., Heath P.T., Slack M.P. et. al. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster // Lancet.- 1997.- Vol.26.- P.1197-202.
  43. Bottiger M., Romanus V., de Verdier C., Boman G. Osteitis and other complications caused by generalized BCG-itis. Experiences in Sweden // Acta Paediatr Scand.- 1982.- Vol.71.- P.471-478.
  44. Butler J.C., Breiman R.F., Campbell J.F., Lipman H.B., Broome C.V., Facklam R.R. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations // JAMA.- 1993.- Vol.270.- P.1826-1831.
  45. Casanova J.L., Blanche S., Emile J.F., Jouanguy E., Lamhamedi S., Altare F., Stephan J.L., Bernaudin F., Bordigoni P., Turck D., Lachaux A., Albertini M., Bourrillon A., Dommergues J.P., Pocidalo M.A., Le Deist F., Gaillard J.L., Griscelli C., Fischer A. Idiopathic disseminated bacillus Calmette-Guerin infection: a French national retrospective study // Pediatrics.- 1996.- Vol.98.- P.774-778.
  46. Champsaur H.F., Bottazzo G.F., Bertrams J., Assan R., Bach C. Virologic, immunologic, and genetic factors in insulin-dependent diabetes mellitus // J Pediatr.- 1982.- Vol.100.- P.15-20.
  47. Chang S.K., Farrell D.L., Dougan K., Kobayashi B. Acute idiopathic thrombocytopenic purpura following combined vaccination against measles, mumps, and rubella // J Am Board Fam Pract.- 1996.- Vol.9.- P.53-55.
  48. Clemens R., Safary A., Hepburn A., Roche C., Stanbury W.J., Andre F.E. Clinical experience with an inactivated hepatitis A vaccine // J Infect Dis.- 1995.- Vol.171.- Suppl 1.- S44-S49.
  49. Colquhoun A.J., Nicholson K.G., Botha J.L., Raymond N.T. Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes // Epidemiol Infect.- 1997.- Vol.119.- P.335-341.
  50. Cox N.H., Forsyth A. Thiomersal allergy and vaccination reactions. // Contact Dermatitis.- 1988.- Vol.18.- P.229-233.
  51. Dahlquist G., Blom L., Lonnberg G. The Swedish Childhood Diabetes Study a multivariate analysis of risk determinants for diabetes in different age groups // Diabetologia.- 1991.- Vol.34.- P.757-762.
  52. Dankov E., Kasal P., Bergmannov V., Stehlнkov J., Domorzkov E. Immunologic findings in children with abnormal reactions after vaccinatio // Cesk Pediatr.- 1993.- Vol.48.- P.9-12.
  53. Dannemann A., van Ree R., Kulig M., Bergmann R.L., Bauer P., Forster J., Guggenmoos-Holzmann I., Aalberse R.C., Wahn U. Specific IgE and IgG4 immune responses to tetanus and diphtheria toxoid in atopic and nonatopic children during the first // Int Arch Allergy Immunol.- 1996.- Vol.111.- P.262-267.
  54. Dautzenberg B. Prevention of tuberculosis // Rev Pneumol Clin.- 1994.- Vol.50.- P.275-279.
  55. Davis R.L., Marcuse E., Black S., Shinefield H., Givens B., Schwalbe J., Ray P., Thompson R.S., Chen R. MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team // Pediatrics.- 1997.- Vol.100.- P.767-771.
  56. De Ritis L., Pecorari R. Thrombopenic purpura following measles vaccination // Pediatr Med Chir.- 1990.- Vol.12.- P.161-163.
  57. Deivanayagam N., Mala N., Ahamed S.S., Shankar V.J. Measles associated diarrhea and pneumonia in south India // Indian Pediatr 1994 Jan;31(1):35-40.
  58. Dias P.G. Anti-hepatitis B and anti-Haemophilus influenzae type b vaccines. Acta Med Port.- 1997.- Vol.10.- P.129-138.
  59. Diepersloot R.J., Bouter K.P., Bruining G.J., Molenaar J.L., Hoekstra J.B., Masurel N., Erkelens D.W. No evidence for the enhanced production of insulin autoantibodies after confrontation with common viral antigens in insulin dependent diabetes mellitus // Neth J Med.- 1990.- Vol.37.- P.225-230.
  60. Echevarria J.M., et al. Infection by hepatitis virus among the indigenous populations of South America: a review of the problem // Invest Clin.- 1996.- Vol.37.- P.191-200.
  61. Ehrengut W. Neural complications after diphtheria vaccination and inoculations with diphtheria toxoid-mixed vaccines. Observations on their etiopathogenesis // Dtsch Med Wochenschr.- 1986.- Vol.111.- P.939-942.
  62. Farrington P., Pugh S., Colville A., Flower A., Nash J., Morgan-Capner P., Rush M., Miller E. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines // Lancet.- 1995.- Vol.345.- P.567-569.
  63. Fawcett H. A., Smith N.P. Injection-site granuloma due to aluminum // Arch Dermatol 1984.- Vol.120.- P.1318-1322.
  64. Frenkel L.M., Nielsen K., Garakian A., Cherry J.D. A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection // Arch Pediatr Adolesc Med.- 1994.- Vol.148.- P.57-60.
  65. Fukuda S., Ishikawa K., Inuyama Y. Acute measles infection in the hamster cochlea // Acta Otolaryngol Suppl (Stockh).- 1994.- Vol.514.- P.111-116.
  66. Geissler W., Pumberger W., Wurnig P., Stuhr O. BCG osteomyelitis as a rare cause of mediastinal tumor in a one-year-old child // Eur J Pediatr Surg.- 1992.- Vol.2.- Vol.118-121.
  67. General Recommendation on Immunization Recommendation of the Advisory on Immunization Practices (ACIP), MMWR, 1994.
  68. Gifford C.G., Gonsior E.C., Villacorte G.V., Bewtra A., Townley R.G. Pertussis booster vaccination and immediate hypersensitivity // Ann Allergy.- 1985.- Vol.54.- P.483-485.
  69. Gillick M.R., Ditzion B. Influenza vaccination. Are we doing better than we think // Arch Intern Med.- 1991.- Vol.151.- P.1742-1744.
  70. Giovanardi Rossi P., Nanni A.G., Gambi D., et.al. Juvenile myasthenia gravis of possible post-vaccinal inoculation. Riv Neurol.- 1976.- Vol.46.- P.265-296.
  71. Grabowski  N., May J.J., Pratt D.S., Richtsmeier W.J., Bertino J.S. The effect of split virus influenza vaccination on theophylline pharmacokinetics // Am Rev Respir Dis.- 1985.- Vol.131.- P. 934-938.
  72. Grimfors G., Bjorkholm M., Hammarstrom L., Askergren J., Smith C.I., Holm G. Type-specific anti-pneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients // Eur J.Haematol.- 1989.- Vol. 43.- P. 404-410.
  73. Gurses N., Aydin M. Intracranial tuberculoma // Microbiyol Bul.- 1992.- Vol.26.- P.163-169.
  74. Hashimoto T. BCG vaccines for the prevention of tuberculosis in the world // Kekkaku 1997.- Vol.72.- P.629-637.
  75. Hayden G.F., Frayha H., Kattan H., Mogarri I. Structured guidelines for the use of influenza vaccine among children with chronic pulmonary disorders // Pediatr Infect Dis J.- 1995.- Vol.14.- P.895-899.
  76. Heijbel H., Chen R.T., Dahlquist G. Cumulative incidence of childhood-onset IDDM is unaffected by pertussis immunization // Diabetes Care.- 1997.- Vol.20.- P.173-175.
  77. Helmke K., Otten A., Willems W.R., Brockhaus R., Mueller-Eckhardt G., Stief T., Bertrams J., Wolf H., Federlin K. Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination // Diabetologia.- 1986.- Vol.29.- P.30-33.
  78. Hengster P., Solder B., Fille M. et.al. Surgical treatment of bacillus Calmette Guerin lymphadenitis // World J Surg.- 1997.- Vol.21.- P.520-523.
  79. Heydolph F., Merkel S., Brock C., Arndt R. BCG osteomyelitis and arthritis // Z Erkr Atmungsorgane.- 1990.- Vol.175.- P.90-94.
  80. Hibberd P.L., Rubin R.H. Prevention of cytomegalovirus infection in the pediatric renal transplant recipient // Pediatr Nephrol.- 1991.- Vol.5.- P.112-117.
  81. Hiltunen M., Hyoty H., Leinikki P., Akerblom H.K., Tuomilehto J., Vesikari T. Low mumps antibody levels induced by mumps-measles-rubella vaccinations in type 1 diabetic children // Diabet Med.- 1994.- Vol.11.- P.942-946.
  82. Howson C.P., Fineberg H.V. Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine // JAMA.- 1992.- Vol.267.- P.392-396.
  83. Hugosson S., Olcen P., Ekedahl C., Acute epiglottitis-aetiology, epidemiology and outcome in a population before large-scale Haemophilus influenzae type b vaccination // Clin Otolaryngol.- 1994.- Vol.19.- P.441-445.
  84. Humphreys F. Acute urticaria and angio-oedema following Haemophilus influenzae b vaccination // Br J Dermatol.- 1994.- Vol.131.- P.582-583.
  85. Hyoty H., Hiltunen M., Reunanen A., Leinikki P., Vesikari T., Lounamaa R., Tuomilehto J., Akerblom H.K. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Childhood Diabetes in Finland Study Group // Diabetologia.- 1993.- Vol.36.- P.1303-1308.
  86. Ikematsu H., Kashiwagi S. Efficacy and adverse reactions of influenza vaccine in the elderly // Nippon Rinsho.- 1997.- Vol.55.- P.2751-2757.
  87. Immunization of Adolescents: Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association (RE9711).- Pediatrics Vol.99.- 1997.- P.479-488.
  88. Jacob C.M., Pastorino A.C., Azevedo A.M., Marques H.H., Sato H.K., Ferrazole L., Aquino M.Z., Sakane P.T., Grumach A.S. Mycobacterium bovis dissemination (BCG strain) among immunodeficient Brazilian infants // J Investig Allergol. Clin Immunol.- 1996.- Vol.6.- P.202-206.
  89. Jaheway C.A., Travers P. Immunology: The immune system in health and sisease / Second ed.- Publishing Inc, 1996.
  90. Jilg W. Hepatitis B vaccination of children and adolescents // Fortschr Med.- 1997.- Vol.115.- P.26, 29-32, 33.
  91. Johnson C.E., Kumar M.L., Whitwell J.K. et.al. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs.eleven to thirteen years // Pediatr. Infect. Dis.J.- 1996.- Vol.15.- P.687-692.
  92. Jonville-Bera A.P., Autret E., Galy-Eyraud C., Hessel L. Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilance centres and pasteur-merieu serums et vaccins // Pediatr Infect Dis J.- 1996.- Vol.15.- P.44-48.
  93. Jovanovic D., Delvaux A.M. Clinical acceptability of live influenza vaccine in high risk subjects and children. Experience with three consecutive recombinant strains // Dev Biol Stand.- 1977.- Vol.39.- P.105-112.
  94. Juntunen-Backman K., Peltola H., Backman A., Salo OP Safe immunization of allergic children against measles, mumps, and rubella // Am J Dis Child.- 1987.- Vol.141.- P.1103-1105.
  95. Kaaber K., Nielsen A.O., Veien N.K. Vaccination granulomas and aluminium allergy: course and prognostic factors // Contact Dermatitis.- 1992.- Vol.26.- P.304-306.
  96. Kaganov B.S., Grishina M.E., Martynova M.I., Rachinskii S.V., Turina I.E., Gerasimov A.A., Nisevich N.F., Ust'kachkintsev V.A. Frequency of detection of hepatitis B markers in various chronic diseases in children // Pediatriia.- 1992.- Vol.1.- P.51-55.
  97. Katz S.L. Future vaccines and a global perspective // Lancet.- 1997.- Vol.350.- P.1767-1770.
  98. Katzir Z., Okon E., Ludmirski A. et.al. Generalized lymphadenitis following B.C.G. vaccination in an immunocompetent 12-year-old boy // Eur J Pediatr.- 1984.- Vol.141.- P.165-167.
  99. Kava T. Acute respiratory infection, influenza vaccination and airway reactivity in asthma // Eur J Respir Dis Suppl.- 1987.- Vol.150.- P.1-38.
  100. Kiec-Swierczynska M. Allergic reaction to merthiolate (a disinfectant) based on material from the Occupational Medicine Institute in Lodz // Med Pr.- 1996.- Vol.47.- P.125-131.
  101. Kiefaber R.W. Thrombocytopenic purpura after measles vaccination // N Engl J Med.- 1981.- Vol.305.- P.225.
  102. Kimmel S.R., Madon-Kay D., Burns I.T. et.al. Breaking the barriers to childhood immunization // Am Fam Physician.- 1996.- Vol.53.- P.1648-1666.
  103. Klinge J., Hammersen G., Scharf J., Lutticken R., Reinert R.R. Overwhelming postsplenectomy infection with vaccine-type Streptococcus pneumoniae in a 12-year-old girl despite vaccination and antibiotic prophylaxis // Infection.- 1997.- Vol.25.- P.368-371.
  104. Koga K., Kawashiro N., Araki A., et.al. Bilateral acute profound deafness after MMR vaccination – report of a case // Nippon Jibiinkoka Gakkai Kaiho.- 1991.- Vol.94.- P.1142-1145.
  105. Konadu E.Y., Parke J.C. Jr, Tran H.T., Bryla D.A., Robbins J.B., Szu S.C. Investigational vaccine for Escherichia coli O157: phase 1 study of O157 O-specific polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugates in adults // J Infect Dis.- 1998.- Vol.177.- P.383-387.
  106. Kostinov M.P., Balabolkin I.I., Pereverzeva N.V., Bogatyreva E.Ia, Gervazieva V.B. Vaccination of children with allergic diseases in foci of diphtheria infection // Pediatriia.- 1991.- N.6.- P.24-28.
  107. Kristensen K. Antibody response to a Haemophilus influenzae type b polysaccharide tetanus toxoid conjugate vaccine in splenectomized children and adolescents // Scand J Infect Dis.- 1992.- Vol.24.- P.629-632.
  108. Kruppenbacher J.P., Mertens T., Adrian M., Smolenski S., Leidel J., Eggers H.J. Vaccine poliomyelitis as a complication of oral vaccination // Offentl Gesundheitswes.- 1983.- Vol.45.- P.528-531.
  109. Kruger L., Katila M.L., Korppi M., Brander E., Pietikдinen M. Rapid decrease in tuberculin skin test reactivity at preschool age after newborn vaccination // Acta Paediatr.- 1992.- Vol.81.- P.678-681.
  110. Lacour M., Maherzi M., Vienny H., Suter S. Thrombocytopenia in a case of neonatal mumps infection: evidence for further clinical presentations // Eur J Pediatr.- 1993.- Vol.152.- P.739-741.
  111. Landesman S.H., Schiffman G. Assessment of the antibody response to pneumococcal ccine in high-risk populations // Rev Infect Dis.- 1981.- Vol.3.- Supp l.- S.184-S197.
  112. Layward L., Allen A.C., Harper S.J., Hattersley J.M., Feehally J Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy // Clin Exp Immunol.- 1992.- Vol.88.- P.394-398.
  113. Leach A., Twumasi P.A., Kumah S. et. al., Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine // J Infect Dis.- 1997.- Vol.175.- P.200-204.
  114. Lecuona E., Azuara A.E.L., Eguilus C. et.al., Responses to triple viral and tetanus vaccination in HIV-infected children // An Esp Pediatr.- 1996.- Vol.44.- P.317-320.
  115. Lee S.Y., Komp D.M., Andiman W. Thrombocytopenic purpura following varicella-zoster vaccination // Am J Pediatr Hematol Oncol.- 1986.- Vol.8.- P.78-80.
  116. Levy J. Vaccination of children in 1996 // Rev Med Brux.- 1996.- Vol.17.- P.250-252.
  117. Louie J.S., Nies K.M., Shoji K.T., Fraback R.C., Abrass C., Border W., Cherry J.D., Imagawa D. Clinical and antibody responses after influenza immunization in systemic lupus erythematosus // Ann Intern Med.- 1978.- Vol.88.- P.790-792.
  118. Ludvigsson J. Immunological aspects on IDDM in children // Indian J Pediatr.- 1989.- Vol.56.- Suppl 1.- S7-S14.
  119. Mascola J.R., Snyder S.W., Weislow O.S., et al. Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group // J Infect Dis.- 1996.- Vol.173.- P.340-348.
  120. Mayser P. BCG Vaccination and Tuberculous Meningitis // MMW Munch Med Wochenschr.- 1977.- Vol.119.- P.75-78.
  121. Meijer P.J. Osteomyelitis as complication of BCG vaccination // Ned Tijdschr Geneeskd.- 1995.- Vol.139.- P.2759.
  122. Monafo W.J., Haslam D.B., Roberts R.L. et.al. Disseminated measles infection after vaccination in a child with a congenital immunodeficiency // J Pediatr.- Vol.124.- P.273-276.
  123. Mori T., Yamauchi Y., Shiozawa K. Lymph node swelling due to bacille Calmette-Guerin vaccination with multipuncture method // Tuber Lung Dis.- 1996.- Vol.77.- P.269-273.
  124. Moulia-Pelat J.P., Spiegel A., Excler J.L., et.al, Control of hepatitis B in French Polynesia with a program of systematic vaccination of newborns with the Genhevac B vaccine // Sante.- 1996.- Vol.6.- P.11-15.
  125. Murdoch I.A., Dos Anjos R. Continued need for pneumococcal prophylaxis after splenectomy // Arch Dis Child.- 1990.- Vol.65.- P.1268-1269.
  126. Nabe-Nielsen J., Walter B. Unilateral total deafness as a complication of the measles-mumps-rubella vaccination // Scand Audiol Suppl.- 1988.- Vol.30.- P.69-70.
  127. Narain J.P., Khare S., Rana S.R. et. al. Epidemic measles in an isolated unvaccinated population // India. Int J Epidemiol.- 1989.- Vol.18.- P.952-958.
  128. National Advisory Committee on Immunization (NACI). Supplementary statement MMR vaccine and anaphylactic hypersensitivity to egg or egg-related antigens // Can Commun Dis Rep.- 1996.- Vol.22.- P.113-115.
  129. Nieminen U., Peltola H., Syrjala M.T., Makipernaa A., Kekomaki R. Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients // Acta Paediatr.- 1993.- Vol.82.- P.267-270.
  130. Nokes D.J., Anderson R.M. Vaccine safety versus vaccine efficacy in mass immunisation programmes // Lancet.- 1991.- Vol.338.- P.1309-1312.
  131. Onile B.A. Review of group B streptococci and their infections // Afr J Med Med Sci.- 1985.- Vol.14.- P.131-143.
  132. Osawa J., Kitamura K., Ikezawa Z., Nakajima H. A probable role for vaccines containing thimerosal in thimerosal hypersensitivity // Contact Dermatitis.- 1991.- Vol.24.- P.178-182.
  133. Osteitis and other complications caused by generalized BCG-itis. Experiences in Sweden // Acta Paediatr Scand.- 1982.- Vol.71.- P.471 -478.
  134. Otten A., Helmke K., Stief T., Mueller-Eckhard G., Willems W.R., Federlin K. Mumps, mumps vaccination, islet cell antibodies and the first manifestation of diabetes mellitus type I // Behring Inst Mitt.- 1984.- Vоl.75.- P.83-88.
  135. Paralytic poliomyelitis United States, 1980-1994. MMWR // Morb Mortal Wkly Rep.- 1997.- Vol.46.- P.79-83.
  136. Passalacqua G., Bagnasco M., Battifora M., Canonica G.W. Adhesion Molecules and Allergy - Recent Insights // ACII.- Vol.10.- P.23-29.
  137. Pasternack A., Mustonen J., Leinikki P. Humoral immune response in patients with IgA and IgM glomerulonephritis // Clin Exp Immunol.- 1986.- Vol.63.- P.228-233.
  138. Peltola H., Heinonen O.P., Valle M. et.al. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program // N Engl J Med.- 1994.- Vol.331.- P.1397-1402.
  139. Peters V.B., Sood S.K. Immunity to Haemophilus influenzae type b polysaccharide capsule after vaccination with the complete series of oligosaccharide CRM197 conjugate vaccine in infants with human immunodeficiency virus infection // J Pediatr.- 1996.- Vol.128.- P.363-365.
  140. Phadke M.A., Joshi B.N., Warerkar U.V., Diwan M.P., Panse G.A., Sokhey J., Bhate S.M. Toxic shock syndrome: an unforeseen complication following measles vaccination // Indian Pediatr.- 1991.- Vol.28.- P.663-665.
  141. Pierce C., Goldstein M., Suozzi K. et.al. The impact of the standards for pediatric immunization practices on vaccination coverage levels // JAMA.- 1996.- Vol.276.- P.626-630.
  142. Pozzetto B., Genin C., Gaudin O.G., Berthoux F.C., Alloin B., Laurent B., Ros A. Live poliovirus vaccine in patients with chronic glomerulonephritis: effects on renal function and specific antibody response // Clin Nephrol.- 1987.- Vol.4.- P.194-198.
  143. Prandota J., Zwolinska D. 2 cases of acute renal failure in children following Di-Te-Per vaccination // Pediatr Pol.- 1978.- Vol.53.- P.215-217.
  144. Valenta R., Vrtala S., Laffer S. et. al. Recombinant allergens // Allergy.- 1998.- Vol.53.- P.552-561.
  145. Rodeghiero F., Frezzato M., Schiavotto C., Castaman G., Dini E. Fulminant sepsis in adults splenectomized for idiopathic thrombocytopenic purpura // Haematologica.- 1992.- Vol.77.- P.253-256.
  146. Ruben F.L., Cate T.R. Influenza pneumonia // Semin Respir Infect.- 1987.- Vol.2.- P.122-129.
  147. Ruben F.L., Fireman P., LaPorte R.E,. Drash A.L., Uhrin M., Vergona R. Immune responses to killed influenza vaccine in patients with type 1 diabetes: altered // J Lab Clin Med.- 1988.- Vol.112.- P.595-602.
  148. Sakaguchi M., Nakayama T., Inouye S. Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines // J Allergy Clin Immunol.- 1996.- Vol.98.- P.1058-1061.
  149. Serwint J.R., Miller R.M., Korsch B.M. Influenza type A and B infections in hospitalized pediatric patients. Who should be immunized // Am J Dis Child 1991.- Vol.145.- P.623-626.
  150. Shatney C.H. Complications of splenectomy // Acta Anaesthesiol Belg.- 1987.- Vol.38.- P.333-339.
  151. Siani P., Amato L., Cirillo G., D'Adamo G., Dello Iacono I., Longo D., Montini T., Mottola L., Occhinegro A., Quarantiello F., et al. The attitude and vaccination practice of a sample of Campania pediatricians // Pediatr Med Chir.- 1994.- Vol.16.- P.301-303.
  152. Spiegelberg H.L., Tighe H., Roman M., Beck L., Raz E. Downregulation of IgE antibody formation by allergen gene immunization // ACI International.- 1998.- Vol.10.- P.52-58.
  153. Spiegelberg H.L., Orozco E.M., Roman M., Raz E. DNA immunization – a novel approch to allergen-specific immunoterapy // Allergy.- 1997.- Vol.52.- P.964-970.
  154. Spika J.S., Halsey N.A., Le C.T., Fish A.J., Lum G.M., Lauer B.A., Schiffman G., Giebink G.S. Decline of vaccine-induced antipneumococcal antibody in children with nephrotic syndrome // Am J Kidney Dis.- 1986.- Vol.7.- P.466-470.
  155. Stables G.I., Forsyth A., Lever R.S. Patch testing in children // Contact Dermatitis.- 1996.- Vol.34.- P.341-344.
  156. Stogmann W., Junker E. Guidelines for tuberculin diagnosis. Consensus paper of the Austrian Society of Lung Diseases and Tuberculosis // Wien Med Wochenschr.- 1994.- Vol.144.- P.163-167.
  157. Stratton K.R., Howe C.J., Johnston R.B. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine // JAMA.- 1994.- Vol.271.- P.1602-1605.
  158. Sugiura A., Yamada A. Aseptic meningitis as a complication of mumps vaccination // Pediatr Infect Dis J.- 1991.- Vol.10.- P.209-213.
  159. Takala A.K., Eskola J., Peltola H., Makela P.H. Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine // Pediatr Infect Dis J.- 1989.- Vol.8.- P.297-302.
  160. Talbot E.A., Perkins M.D., Fagundes S., Silva M., Frothingham R. Disseminated bacille Calmette-Guerin disease after vaccination: case report and review // Clin Infect Dis.- 1997.- Vol.24.- P.1139-1146.
  161. Tanska A. Engerix B vaccine in prophylaxis of hepatitis B virus infection in children with diabetes // Wiad Lek.- 1994.- Vol.47.- P.107-110.
  162. Tejani A., Fikrig S., Schiffman G., Gurumurthy K Persistence of protective pneumococcal antibody following vaccination in patients with the nephrotic syndrome // Am J Nephrol.- 1984.- Vol.4.- P.32-37.
  163. Telahun M., Abdulkadir J., Kebede E. The relation of early nutrition, infections and socio-economic factors to the development of childhood diabetes // Ethiop Med J.- 1994.- Vol.32.- P.239-244.
  164. Tezzon F., Tomelleri P., Ferrari G., Sergi A. Acute radiculomyelitis after antitetanus vaccination // Ital J Neurol Sci.- 1994.- Vol.15.- P.191-193.
  165. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices // MMWR Morb Mortal Wkly Rep.- 1996.- Vol.26.- Rr-4.- P.1-18.
  166. Tounian P., Delacourt C., de Blic J., Paupe J., Scheinmann P. Vaccinations of children allergic to eggs with vaccine prepared with egg // Arch Fr Pediatr.- 1993.- Vol.50.- P.191-195.
  167. Trotter A.C., Stone B.D., Laszlo D.J., Georgitis J.W. Measles, mumps, rubella vaccine administration in egg-sensitive children: systemic reactions during vaccine desensitization // Ann Allergy.- 1994.- Vol. 72.- P. 25-28.
  168. Udani P.M. BCG vaccination in India and tuberculosis in children: newer facets // Indian J Pediatr.- 1994.- Vol.61.- P.451-462.
  169. Understanding Vaccines. NIH Publication N 98-4219, January 1998 - P.1-35.
  170. Update: Vaccine Side Effects, Adverse Reactions, Contraindications, and Precautions. Recommendations of the Advisory Committee on Immunization Practices // MMWR Morb Mortal Wkly Rep.- 1996.- Vol.45.- Rr-12.- P.1-35.
  171. Van der Meer H., Kimpen J.L. Insufficient vaccination status of children with a chronic disease // Ned Tijdschr Geneeskd.- 1996.- Vol.140.- P.1402-1406.
  172. Van der Walt J.H., Roberton D.M. Anaesthesia and recently vaccinated children // Paediatr Anaesth.- 1996.- Vol.6.- P.135-141.
  173. Vetter R.T., et al. Vaccination update. Hib, hepatitis, polio, varicella, influenza, pneumococcal and meningococcal disease // Postgrad Med.- 1995.- Vol.98.- P.141-144.
  174. Vittori F., Groslafeige C. Tuberculosis lupus after BCG vaccination. A rare complication of the vaccination // Arch Pediatr.- 1996.- Vol.3.- P.457-459.
  175. Vlacha V., Forman E.N., Miron D., Peter G. Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination // Pediatrics.- 1996.- Vol.97.- P.738-739.
  176. Von Kries R., Bohm O., Windfuhr A. Haemophilus influenzae b-vaccination: the urgency for timely vaccination // Eur J Pediatr.- 1997.- Vol.156.- P.282-287.
  177. Von Muhlendahl K.E. Side effects and complications of measles-mumps vaccination // Monatsschr Kinderheilkd.- 1989.- Vol.137.- P.440-446.
  178. Waldo F.B. Systemic immune response after mucosal immunization in patients with IgA nephropathy // J Clin Immunol.- 1992.- Vol.12.- P.21-26.
  179. Walter S., Handrick W., Tischer W., Hormann D., Borte M. BCG-vaccination in neonates as a cause of osteomyelitis--an argument against BCG-vaccination // Klin Padiatr.- 1994.- Vol.206.- P.433-436.
  180. Warner J.O., Jackson W.F. Pediatric Allergy / Wolfe Publishing, an imprint of Mosby-Year Book Europe, 1994.- P.128.
  181. Wiersbitzky S., Ballke E.H., Burghardt R., Spangenberg U., Joswig T., Baufeld W., Ordt H.A., Paul W. Long-term study of various immunologic functions in children with chronic nonspecific lung diseases // Z Erkr Atmungsorgane.- 1985.- Vol.164.- P.241-253.
  182. Withagen M.I., Ruitenberg A., van Soolingen D., Rumke H.C., Diepstraten A.F., de Groot R. Osteomyelitis as a complication following BCG vaccination // Ned Tijdschr Geneeskd.- 1995.- Vol.139.- P.2047-2050.
  183. Wolff M., Dopfer R., Hassberg D., Niethammer D. BCGitis as a cause of mediastinal tumor // Monatsschr Kinderheilkd.- 1993.- Vol.141.- P.409-411.
  184. Wood D., Halfon N., Pereyra M. et.al. Knowledge of the childhood immunization schedule and of contraindications to vaccinate by private and public providers in Los Angeles // Pediatr Infect Dis J.- 1996.- Vol.15.- P.140-145.
  185. Wortis N., Strebel P.M., Wharton M., Bardenheier B., Hardy I.R. Pertussis deaths: report of 23 cases in the United States, 1992 and 1993 // Pediatrics.- 1996.- Vol.97.- P.607-612.
  186. Yamamoto T., Kino T., Yagi K., Miyata H., Yoshioka K. Acute thrombocytopenic purpura following rubella vaccination // Rinsho Ketsueki.- 1996.- Vol.37.- P.1328-1330.
  187. Yang X., Wang H., Xiang H.D. Investigation of the form of onset in 139 cases of insulin-dependent diabetes mellitus // Chung Hua Nei Ko Tsa Chih.- 1994.- Vol.33.- P.37-39.
  188. Zepp F., Knuf M., Habermehl P., et.al. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. // Infect Immun.- 1996.- Vol.10.- P.4078-4084.
  189. Zielen S, Buhring I. Vaccination of chronically ill chldren // Z. Arztl Fortbild Qualitatssich.- 1997.- Vol.91.- Vol.213-217.
  190. Zimmerman R.K., Ruben F.L., Ahwesh E.R. Influenza, influenza vaccine, and amantadine/rimantadine // J Fam Pract.- 1997.- Vol.45.- P.107-122.

© 2000-2007 НИИАХ СГМА Rambler's Top100 TopList Rambler's Top100